|
|
|
Volumn 60, Issue 4, 2006, Pages 211-212
|
|
Serum prolactin, leptin, lipids and lipoproteins levels during antipsychotics treatment in Parkinson's disease and related psychosis.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIPARKINSON AGENT;
BENZODIAZEPINE DERIVATIVE;
DIBENZOTHIAZEPINE DERIVATIVE;
LEPTIN;
LIPID;
LIPOPROTEIN;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
ARTICLE;
BLOOD;
BODY MASS;
HUMAN;
PARKINSON DISEASE;
PSYCHOSIS;
ANTIPARKINSON AGENTS;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
BODY MASS INDEX;
DIBENZOTHIAZEPINES;
HUMANS;
LEPTIN;
LIPIDS;
LIPOPROTEINS;
PARKINSON DISEASE;
PSYCHOTIC DISORDERS;
RISPERIDONE;
|
|
EID: 33747149310
PISSN: 0350199X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (16)
|
|
References (0)
|
